Hangzhou Tigermed reports stable capital position for August 2025

Hangzhou Tigermed Consulting Co., Ltd. submitted its monthly statement of changes in securities for August 2025, confirming no changes in its statutory/registered share capital or issued shares during the reporting period. The company's total statutory/registered share capital remained at RMB 861,026,050, comprising RMB 737,901,250 for A-shares and RMB 123,124,800 for H-shares.

The total number of issued A-shares stood at 732,017,470, with 5,883,780 A-shares held as treasury stock, making the total issued A-shares 737,901,250. Similarly, the total number of issued H-shares remained at 123,124,800, with no H-shares held as treasury stock.

The company had repurchased a total of 9,806,300 A-shares across several periods from May 23, 2024, to February 21, 2025, which were held as treasury shares. As of August 31, 2025, the company held 5,883,780 A-shares as treasury stock after the cancellation of 3,922,520 treasury shares on May 29, 2025.